India's pharmaceutical landscape is witnessing a substantial rise in API companies. Fueled by rising global requirement and favorable government policies, the country’s drug manufacturing domain has arisen as a important contributor to the worldwide medical system. This surge is creating many chances for capital and job creation across the region